BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29626374)

  • 1. Cleaved caspase-3 expression is a potential prognostic factor for endometrial cancer with positive peritoneal cytology.
    Ogane N; Yasuda M; Kato H; Kato T; Yano M; Kameda Y; Kamoshida S
    Cytopathology; 2018 Jun; 29(3):254-261. PubMed ID: 29626374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
    Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
    Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.
    Lax SF; Pizer ES; Ronnett BM; Kurman RJ
    Hum Pathol; 1998 Jun; 29(6):551-8. PubMed ID: 9635673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
    Wang L; Li L; Wu M; Lang J
    Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of Ki-67 antigen expression in tissue microarray method in prediction prognosis of patients with endometrioid endometrial cancer].
    Gottwald L; Kubiak R; Sek P; Piekarski J; Szwalski J; Pasz-Walczak G; Spych M; Suzin J; Tylińskis W; Jeziorski A
    Ginekol Pol; 2013 Jun; 84(6):444-9. PubMed ID: 24032262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
    Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
    Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of abnormal peritoneal cytology on survival of women with stage I-II endometrioid endometrial cancer.
    Matsuo K; Yabuno A; Hom MS; Shida M; Kakuda M; Adachi S; Mandelbaum RS; Ueda Y; Hasegawa K; Enomoto T; Mikami M; Roman LD
    Gynecol Oncol; 2018 May; 149(2):301-309. PubMed ID: 29605499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma.
    Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V
    Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L1 Cell Adhesion Molecule as a Predictor of Disease-Specific Survival and Patterns of Relapse in Endometrial Cancer.
    Pasanen A; Tuomi T; Isola J; Staff S; Bützow R; Loukovaara M
    Int J Gynecol Cancer; 2016 Oct; 26(8):1465-71. PubMed ID: 27648714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic significance of positive peritoneal cytology in endometrial cancer and its correlations with L1-CAM biomarker.
    Vizza E; Mancini E; Laquintana V; Loria R; Carosi M; Baiocco E; Cicchillitti L; Piaggio G; Patrizi L; Sperduti I; Zampa A; Cutillo G; Falcioni R; Corrado G
    Surg Oncol; 2019 Mar; 28():151-157. PubMed ID: 30851892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant peritoneal cytology and decreased survival of women with stage I endometrioid endometrial cancer.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Machida H; Nagase Y; Grubbs BH; Roman LD; Wright JD; Harter P; Klar M
    Eur J Cancer; 2020 Jul; 133():33-46. PubMed ID: 32434109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
    Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an immunocytochemical double-labeling staining can display the distribution of Bcl-2/Ki-67 cells in endometrial adenocarcinomas as well as in normal endometrium.
    Mourtzikou A; Kosmas K; Marouga A; Stamouli M; Pouliakis A; Karakitsos P
    Clin Lab; 2012; 58(1-2):133-44. PubMed ID: 22372356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progesterone receptor negativity is an independent risk factor for relapse in patients with early stage endometrioid endometrial adenocarcinoma.
    Huvila J; Talve L; Carpén O; Edqvist PH; Pontén F; Grénman S; Auranen A
    Gynecol Oncol; 2013 Sep; 130(3):463-9. PubMed ID: 23777659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic grade and peritoneal cytology as prognostic factors in type 1 endometrial cancer.
    Tanaka K; Kobayashi Y; Sugiyama J; Yamazaki T; Dozono K; Watanabe M; Shibuya H; Nishigaya Y; Momomura M; Matsumoto H; Umezawa S; Takamatsu K; Iwashita M
    Int J Clin Oncol; 2017 Jun; 22(3):533-540. PubMed ID: 28083737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transtubal spread of endometrial carcinoma: correlation of intra-luminal tumour cells with tumour grade, peritoneal fluid cytology, and extra-uterine metastasis.
    Stewart CJ; Doherty DA; Havlat M; Koay MH; Leung YC; Naran A; O'Brien D; Ruba S; Salfinger S; Tan J
    Pathology; 2013 Jun; 45(4):382-7. PubMed ID: 23635815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of programmed cell death-ligand 1 (PD-L1) and CD8 expression in grade 3 endometrial carcinomas.
    Vagios S; Yiannou P; Giannikaki E; Doulgeraki T; Papadimitriou C; Rodolakis A; Nonni A; Vlachos A; Pavlakis K
    Int J Clin Oncol; 2019 Nov; 24(11):1419-1428. PubMed ID: 31197557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.